期刊文献+

阿卡波糖治疗葡萄糖调节受损患者的临床疗效观察 被引量:4

Clinical Effects in Cases of Impaired Glucose Regulation Treated with Acarbose
下载PDF
导出
摘要 目的探讨阿卡波糖治疗葡萄糖调节受损患者(Impaired glucose regulation,IGR)的临床疗效。方法将初诊88例IGR患者随机分为对照组42例,治疗组46例,对照组仅给予强化饮食和运动教育治疗,治疗组在此基础上给予阿卡波糖治疗。16周后观察患者治疗前后体质量指数(Body mass index,BMI)、空腹血糖(Fasting blood glucose,FBG)、口服糖耐量试验2h血糖(2h blood glucose duringoral glucose tolerance test,2hPBG)、胆固醇(Total cholesterol,TC)、三酰甘油(Triglyceride,TG)、C反应蛋白(C-reactive protein,CRP)的变化。结果对照组、治疗组患者干预后BMI、FBG、2hPBG、TG均较干预前降低(P<0.05)。且治疗组患者FBG、P2hBG降低较对照组明显(P<0.05)。对照组患者CRP治疗前较治疗后略有降低(P>0.05),治疗组CRP治疗前较治疗后明显降低(P<0.05)。结论阿卡波糖可以改善IGR患者的糖代谢及微炎症状态。 Objective To investigate clinical effects in cases of impaired glucose regulation(IGR) treated with acarbose.Methods 88 IGR patients were divided into control group(diet+exercise) and treat group(diet+exercise+acarbose) randomly.To obserse changes before and after treatment include body mass index(BMI),fasting blood glucose(FBG),2h blood glucose during oral glucose tolerance test(2hPBG),total cholesterol(TC),triglyceride(TG),Creactive protein(CRP).Results After treatment,BMI,FBG,2hPBG、TG of Two groups patients dropped and this change was significant treat group than control group(P〈0.05).After treatment,CRP of control group lightly dropped(P〉0.05) and CRP of treat group significantly dropped(P〈0.05).Conclusions Acarbose significantly improve glucose metabolism and small imflammation condition of IGR patients.
作者 石慧
出处 《中国医药指南》 2012年第30期49-50,共2页 Guide of China Medicine
关键词 葡萄糖调节受损 阿卡波糖 血糖 C反应蛋白 Impaired glucose regulation Acarbose Blood glucose C-reactive protein
  • 相关文献

参考文献4

二级参考文献19

  • 1王先令,陆菊明,潘长玉.不同糖耐量水平者血清C反应蛋白水平及阿卡波糖干预的影响[J].中华内分泌代谢杂志,2003,19(4):254-256. 被引量:43
  • 2吴伟华,张巾超,于江波,刘国良.2型糖尿病及合并大血管病变糖尿病患者C反应蛋白水平观察[J].中华内分泌代谢杂志,2003,19(4):257-259. 被引量:68
  • 3胡英华,李光伟.大庆糖尿病发病率调查及21世纪我国糖尿病发病情况...[J].中华内科杂志,1993,32(3):173-175. 被引量:58
  • 4潘孝仁,李光伟,胡英华,王继兴,杨文英,安作新,刘娟,曹辉碧,胡泽溪,庞成言,张辉,郑辉,王金平,姜希贵,姜亚云.饮食和运动干预治疗对糖尿病发病率的影响──530例糖耐量低减人群六年前瞻性观察[J].中华内科杂志,1995,34(2):108-112. 被引量:242
  • 5Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001,103:1813-1818.
  • 6Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 2002,51:1596-1600.
  • 7Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation, 2003,107:398-404.
  • 8Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory marker obese women: a randomized trial. JAMA, 2003,289:1799-1804.
  • 9Mojiminiyi OA, Abdella N, Moussa MA, et al. Association of C-reactive protein with coronary heart diaease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract,2002,58:37-44.
  • 10Temelkova-Kurktschiev T, Henkel E, Schaper F, et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia and underestimated evil? Exp Clin Endocrinol Diabetes, 2000,108:93-99.

共引文献358

同被引文献55

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部